Acrospire Investment Management LLC - REATA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 55 filers reported holding REATA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$68,000
+277.8%
3,137
+348.1%
0.03%
+133.3%
Q3 2016$18,000
+200.0%
700
+133.3%
0.01%
+200.0%
Q2 2016$6,000–300–0.00%–
 Download
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders